Blood Stream Infection Testing is carried out to determine the infection in the bloodstream and detect the causing agent
In the past, blood was the only test accessible for
analyzing blood flow in the bloodstream. Now, various tests for infectious
agents in the bloodstream can be performed simultaneously. These tests are
designed for use in the home setting and can be performed by anyone who values
the health of their patients. In addition to blood flow analysis, new methods
are being developed to evaluate the immune system's response to stress and to
identify other diseases associated with abnormal immune system function. As a
result, several new products have been developed for use in bloodborne
pathogens (AIDS, Hepatitis B, Lymphoma and Meningitis) along with established
products used to test for other diseases. For instance, in October 2021, a
medical equipment making company in the U.S., NanoDx, Inc., partnered with
SkyWater Technology to develop solutions for blood testing to detect COVID-19
infection.
With over 25 million cases of AIDS (acquired immunodeficiency
syndrome) to date, there are more tests than ever being developed
or used in clinical practice. The result is that blood
stream infection testing has become a niche product and is no longer
the standard line of work. Since AIDS infection is fatal, blood stream
infection testing is becoming a priority in many countries. As HIV is not a
genetic disease, people who do not have the virus can carry the infection for
years before becoming symptomatic. In countries where the AIDS epidemic is
growing most rapidly, blood tests for HIV infection have become a popular
diagnostic tool.
Another area experiencing increasing popularity among
medical professionals is the home pregnancy test. For years, urine tests
performed at home have been the only reliable way to predict pregnancies, but
now a rapid advance in disposable testing has introduced a product type known
as the M embryo Transfer Reagent. The product type essentially makes it possible
to rapidly examine the development of an embryo, and thus to determine whether
or not a pregnancy has occurred. As the majority of medical professionals are
already familiar with this kind of rapid testing, the introduction of a product
type that enables rapid examination of a small number of cells simultaneously
has been greeted with a lot of skepticism by medical specialists.
Comments
Post a Comment